1. Home
  2. MLEC vs VVOS Comparison

MLEC vs VVOS Comparison

Compare MLEC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$6.10

Market Cap

5.0M

Sector

Finance

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.16

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
VVOS
Founded
2008
2016
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.8M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MLEC
VVOS
Price
$6.10
$0.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.75
AVG Volume (30 Days)
17.5K
14.5M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.76
EPS
N/A
N/A
Revenue
N/A
$17,443,000.00
Revenue This Year
$20.42
$69.66
Revenue Next Year
$30.00
$48.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.05
52 Week Low
$0.21
$0.16
52 Week High
$23.22
$3.61

Technical Indicators

Market Signals
Indicator
MLEC
VVOS
Relative Strength Index (RSI) 39.63 31.88
Support Level $5.41 $0.16
Resistance Level $9.23 $0.55
Average True Range (ATR) 0.64 0.04
MACD -0.09 0.00
Stochastic Oscillator 4.46 2.27

Price Performance

Historical Comparison
MLEC
VVOS

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: